What are BBTX's recent SEC filings?
RA Capital Management, Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund filed a Joint Filing Agreement as an exhibit to a Schedule 13D regarding their beneficial ownership of Bambusa Therapeutics common stock.
View full filing details →A Schedule 13G was filed regarding beneficial ownership of Bambusa Therapeutics, Inc. (BBTX), accompanied by a joint filing agreement. The filing indicates a passive investor position.
View full filing details →Bambusa Therapeutics filed an amended and restated certificate of incorporation and bylaws in connection with the completion of its initial public offering. The company also disclosed its channels for disseminating material information.
View full filing details →Has BBTX ever done a stock split?
No stock splits are recorded for BBTX.
Get Real-Time BBTX Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free